Today's Analyst Stock Ratings | Upgrades, Downgrades

							Get Alert
Jul 22, 2026	DHRDanaher	$204.85	-4.81%	Brandon CouillardWells Fargo 73%	195 212	Previous Equal-Weight Current Equal-Weight	Get Alert
Jul 22, 2026	DHRDanaher	$204.85	15.21%	Dan BrennanTD Cowen 70%	236 240	Previous Buy Current Buy	Get Alert
Jul 22, 2026	DHRDanaher	$204.85	7.4%	Daniel AriasStifel 81%	220 260	Previous Buy Current Buy	Get Alert
Jul 22, 2026	DHRDanaher	$204.85	-2.37%	Subbu NambiGuggenheim 78%	200 235	Previous Buy Current Buy	Get Alert
Jul 22, 2026	DHRDanaher	$204.85	4.95%	Dan LeonardRBC Capital 68%	200 215	Previous Outperform Current Outperform	Get Alert
Jul 6, 2026	DHRDanaher	$204.85	12.28%	Vijay KumarEvercore ISI Group 63%	230 232	Previous Outperform Current Outperform	Get Alert
Jun 11, 2026	DHRDanaher	$204.85	-2.37%	David WestenbergPiper Sandler 73%	200	Previous Initiates Current Neutral	Get Alert
Jun 3, 2026	DHRDanaher	$204.85	12.28%	Rajesh KumarHSBC 58%	230 270	Previous Buy Current Buy	Get Alert
Jun 2, 2026	DHRDanaher	$204.85	—	Mike PolarkWolfe Research 49%	—	Previous Current Peer Perform	Get Alert
May 27, 2026	DHRDanaher	$204.85	12.28%	Patrick DonnellyCitigroup 64%	230	Previous Current Buy	Get Alert
May 15, 2026	DHRDanaher	$204.85	-2.37%	Dan LeonardRBC Capital 68%	200	Previous Current Outperform	Get Alert
Apr 23, 2026	DHRDanaher	$204.85	24.48%	Kallum TitchmarshMorgan Stanley 37%	255 270	Previous Overweight Current Overweight	Get Alert
Apr 22, 2026	DHRDanaher	$204.85	22.04%	Dan LeonardUBS 68%	250 270	Previous Buy Current Buy	Get Alert
Apr 22, 2026	DHRDanaher	$204.85	3.49%	Brandon CouillardWells Fargo 73%	212 240	Previous Equal-Weight Current Equal-Weight	Get Alert
Apr 22, 2026	DHRDanaher	$204.85	14.72%	Subbu NambiGuggenheim 78%	235 275	Previous Buy Current Buy	Get Alert
Apr 22, 2026	DHRDanaher	$204.85	19.6%	Catherine SchulteBaird 65%	245 249	Previous Outperform Current Outperform	Get Alert
Apr 17, 2026	DHRDanaher	$204.85	21.55%	Catherine SchulteBaird 65%	249 251	Previous Outperform Current Outperform	Get Alert
Apr 14, 2026	DHRDanaher	$204.85	12.28%	Luke SergottBarclays 67%	230 250	Previous Overweight Current Overweight	Get Alert
Apr 13, 2026	DHRDanaher	$204.85	12.28%	Evie KosloskyGoldman Sachs 42%	230 265	Previous Buy Current Buy	Get Alert
Apr 6, 2026	DHRDanaher	$204.85	9.84%	Vijay KumarEvercore ISI Group 63%	225 254	Previous Outperform Current Outperform	Get Alert
Jan 29, 2026	DHRDanaher	$204.85	34.24%	Tycho PetersonJP Morgan 81%	270 275	Previous Overweight Current Overweight	Get Alert
Jan 29, 2026	DHRDanaher	$204.85	29.36%	Tycho PetersonJefferies 81%	255 265	Previous Buy Current Buy	Get Alert
Jan 7, 2026	DHRDanaher	$204.85	31.8%	Dan BrennanTD Cowen 70%	260 270	Previous Buy Current Buy	Get Alert
Jan 5, 2026	DHRDanaher	$204.85	34.24%	Subbu NambiGuggenheim 78%	250 275	Previous Buy Current Buy	Get Alert
Dec 15, 2025	DHRDanaher	$204.85	17.16%	Brandon CouillardWells Fargo 73%	230 240	Previous Equal-Weight Current Equal-Weight	Get Alert
Dec 9, 2025	DHRDanaher	$204.85	29.36%	Evie KosloskyGoldman Sachs 42%	265	Previous Initiates Current Buy	Get Alert
Dec 2, 2025	DHRDanaher	$204.85	31.8%	Kallum TitchmarshMorgan Stanley 37%	270	Previous Initiates Current Overweight	Get Alert
Oct 23, 2025	DHRDanaher	$204.85	12.28%	Brandon CouillardWells Fargo 73%	205 230	Previous Equal-Weight Current Equal-Weight	Get Alert
Oct 22, 2025	DHRDanaher	$204.85	26.92%	Dan BrennanTD Cowen 70%	250 260	Previous Buy Current Buy	Get Alert
Oct 22, 2025	DHRDanaher	$204.85	22.04%	Luke SergottBarclays 67%	225 250	Previous Overweight Current Overweight	Get Alert
Oct 8, 2025	DHRDanaher	$204.85	7.4%	Ed Ridley-DayRothschild & Co 8%	220 245	Previous Buy Current Neutral	Get Alert
Oct 7, 2025	DHRDanaher	$204.85	19.6%	Vijay KumarEvercore ISI Group 63%	226 245	Previous Outperform Current Outperform	Get Alert
Sep 22, 2025	DHRDanaher	$204.85	7.4%	Derik De BruinB of A Securities 72%	220 230	Previous Buy Current Buy	Get Alert
Jul 23, 2025	DHRDanaher	$204.85	9.84%	Dan LeonardUBS 68%	225 240	Previous Buy Current Buy	Get Alert
Jul 23, 2025	DHRDanaher	$204.85	0.07%	Brandon CouillardWells Fargo 73%	205 210	Previous Equal-Weight Current Equal-Weight	Get Alert
Jul 23, 2025	DHRDanaher	$204.85	22.04%	Subbu NambiGuggenheim 78%	250 250	Previous Buy Current Buy	Get Alert
Jul 23, 2025	DHRDanaher	$204.85	11.79%	Catherine SchulteBaird 65%	226 229	Previous Outperform Current Outperform	Get Alert
Jul 18, 2025	DHRDanaher	$204.85	10.32%	Catherine SchulteBaird 65%	225 226	Previous Outperform Current Outperform	Get Alert
Jul 11, 2025	DHRDanaher	$204.85	34.24%	Sung Ji NamScotiabank 56%	275	Previous Sector Perform Current Sector Outperform	Get Alert
Jul 8, 2025	DHRDanaher	$204.85	10.32%	Vijay KumarEvercore ISI Group 63%	226 230	Previous Outperform Current Outperform	Get Alert
Jun 24, 2025	DHRDanaher	$204.85	9.84%	Luke SergottBarclays 67%	215 225	Previous Overweight Current Overweight	Get Alert
Apr 23, 2025	DHRDanaher	$204.85	22.04%	Conor McNamaraRBC Capital 42%	250 250	Previous Outperform Current Outperform	Get Alert
Apr 23, 2025	DHRDanaher	$204.85	17.16%	Matthew SykesGoldman Sachs 64%	240 260	Previous Buy Current Buy	Get Alert
Apr 23, 2025	DHRDanaher	$204.85	22.04%	Subbu NambiGuggenheim 78%	250 250	Previous Buy Current Buy	Get Alert
Apr 23, 2025	DHRDanaher	$204.85	17.16%	Dan LeonardUBS 68%	240 275	Previous Buy Current Buy	Get Alert
Apr 23, 2025	DHRDanaher	$204.85	9.84%	Catherine SchulteBaird 65%	225 231	Previous Outperform Current Outperform	Get Alert
Apr 22, 2025	DHRDanaher	$204.85	4.95%	Luke SergottBarclays 67%	205 215	Previous Overweight Current Overweight	Get Alert
Apr 22, 2025	DHRDanaher	$204.85	26.92%	Tycho PetersonJP Morgan 81%	260 280	Previous Overweight Current Overweight	Get Alert
Apr 22, 2025	DHRDanaher	$204.85	12.28%	Tycho PetersonJefferies 81%	230 260	Previous Buy Current Buy	Get Alert
Apr 16, 2025	DHRDanaher	$204.85	12.77%	Catherine SchulteBaird 65%	231 258	Previous Outperform Current Outperform	Get Alert
Apr 10, 2025	DHRDanaher	$204.85	0.07%	Luke SergottBarclays 67%	205 240	Previous Equal-Weight Current Overweight	Get Alert
Mar 14, 2025	DHRDanaher	$204.85	26.92%	Daniel AriasStifel 81%	260	Previous Hold Current Buy	Get Alert
Feb 3, 2025	DHRDanaher	$204.85	—	Andrew CooperRaymond James 54%	—	Previous Outperform Current Market Perform	Get Alert
Jan 30, 2025	DHRDanaher	$204.85	29.36%	Patrick DonnellyCitigroup 64%	265 285	Previous Buy Current Buy	Get Alert
Jan 30, 2025	DHRDanaher	$204.85	35.22%	Conor McNamaraRBC Capital 42%	277 299	Previous Outperform Current Outperform	Get Alert
Jan 30, 2025	DHRDanaher	$204.85	25.95%	Catherine SchulteBaird 65%	258 268	Previous Outperform Current Outperform	Get Alert
Jan 30, 2025	DHRDanaher	$204.85	17.16%	Brandon CouillardWells Fargo 73%	240 280	Previous Equal-Weight Current Equal-Weight	Get Alert
Jan 30, 2025	DHRDanaher	$204.85	17.16%	Luke SergottBarclays 67%	240 275	Previous Equal-Weight Current Equal-Weight	Get Alert
Jan 29, 2025	DHRDanaher	$204.85	26.92%	Tycho PetersonJefferies 81%	260 285	Previous Buy Current Buy	Get Alert
Jan 21, 2025	DHRDanaher	$204.85	34.24%	Andrew CooperRaymond James 54%	275 300	Previous Outperform Current Outperform	Get Alert
Jan 6, 2025	DHRDanaher	$204.85	39.13%	Patrick DonnellyCitigroup 64%	285 305	Previous Buy Current Buy	Get Alert
Dec 23, 2024	DHRDanaher	$204.85	29.36%	Sung Ji NamScotiabank 56%	265	Previous Initiates Current Sector Perform	Get Alert
Dec 13, 2024	DHRDanaher	$204.85	41.57%	Derik De BruinB of A Securities 72%	290 290	Previous Neutral Current Buy	Get Alert
Oct 31, 2024	DHRDanaher	$204.85	39.13%	Doug SchenkelWolfe Research 71%	285	Previous Peer Perform Current Outperform	Get Alert
Oct 23, 2024	DHRDanaher	$204.85	51.82%	Conor McNamaraRBC Capital 42%	311 333	Previous Outperform Current Outperform	Get Alert
Oct 23, 2024	DHRDanaher	$204.85	53.77%	Dan BrennanTD Cowen 70%	310 315	Previous Buy Current Buy	Get Alert
Oct 23, 2024	DHRDanaher	$204.85	51.33%	Paul KnightKeybanc 54%	290 310	Previous Overweight Current Overweight	Get Alert
Oct 23, 2024	DHRDanaher	$204.85	53.77%	Jacob JohnsonStephens & Co. 57%	315 315	Previous Overweight Current Overweight	Get Alert
Oct 23, 2024	DHRDanaher	$204.85	29.36%	Daniel AriasStifel 81%	250 265	Previous Hold Current Hold	Get Alert
Oct 23, 2024	DHRDanaher	$204.85	48.89%	Dan LeonardUBS 68%	305 309	Previous Buy Current Buy	Get Alert
Oct 23, 2024	DHRDanaher	$204.85	46.45%	Andrew CooperRaymond James 54%	300 310	Previous Outperform Current Outperform	Get Alert
Oct 23, 2024	DHRDanaher	$204.85	34.24%	Luke SergottBarclays 67%	275 285	Previous Equal-Weight Current Equal-Weight	Get Alert
Oct 23, 2024	DHRDanaher	$204.85	35.22%	Catherine SchulteBaird 65%	277 278	Previous Outperform Current Outperform	Get Alert
Oct 1, 2024	DHRDanaher	$204.85	35.71%	Vijay KumarEvercore ISI Group 63%	275 278	Previous Outperform Current Outperform	Get Alert
Oct 1, 2024	DHRDanaher	$204.85	53.77%	Jacob JohnsonStephens & Co. 57%	315	Previous Initiates Current Overweight	Get Alert
Sep 6, 2024	DHRDanaher	$204.85	46.45%	Conor McNamaraRBC Capital 42%	300 300	Previous Outperform Current Outperform	Get Alert
Aug 27, 2024	DHRDanaher	$204.85	36.69%	Brandon CouillardWells Fargo 73%	280	Previous Initiates Current Equal-Weight	Get Alert
Jul 24, 2024	DHRDanaher	$204.85	35.71%	Catherine SchulteBaird 65%	271 278	Previous Outperform Current Outperform	Get Alert
Jul 24, 2024	DHRDanaher	$204.85	46.45%	Conor McNamaraRBC Capital 42%	297 300	Previous Outperform Current Outperform	Get Alert
Jul 24, 2024	DHRDanaher	$204.85	39.13%	Luke SergottBarclays 67%	270 285	Previous Equal-Weight Current Equal-Weight	Get Alert
Jul 24, 2024	DHRDanaher	$204.85	36.69%	—	275 280	Previous Current Outperform	Get Alert
Jul 24, 2024	DHRDanaher	$204.85	22.04%	Daniel AriasStifel 81%	235 250	Previous Hold Current Hold	Get Alert
Jul 24, 2024	DHRDanaher	$204.85	22.04%	Matthew SykesGoldman Sachs 64%	225 250	Previous Neutral Current Neutral	Get Alert
Jul 24, 2024	DHRDanaher	$204.85	51.33%	Dan BrennanTD Cowen 70%	290 310	Previous Buy Current Buy	Get Alert
Jul 24, 2024	DHRDanaher	$204.85	34.24%	Derik De BruinB of A Securities 72%	270 275	Previous Neutral Current Neutral	Get Alert
Jul 2, 2024	DHRDanaher	$204.85	26.92%	Vijay KumarEvercore ISI Group 63%	260 266	Previous Outperform Current Outperform	Get Alert
Apr 24, 2024	DHRDanaher	$204.85	41.57%	Patrick DonnellyCitigroup 64%	280 290	Previous Buy Current Buy	Get Alert
Apr 24, 2024	DHRDanaher	$204.85	41.57%	Dan BrennanTD Cowen 70%	280 290	Previous Buy Current Buy	Get Alert
Apr 24, 2024	DHRDanaher	$204.85	31.8%	Derik De BruinB of A Securities 72%	258 270	Previous Neutral Current Neutral	Get Alert
Apr 24, 2024	DHRDanaher	$204.85	31.8%	Luke SergottBarclays 67%	260 270	Previous Equal-Weight Current Equal-Weight	Get Alert
Apr 24, 2024	DHRDanaher	$204.85	32.29%	Catherine SchulteBaird 65%	259 271	Previous Outperform Current Outperform	Get Alert
Apr 17, 2024	DHRDanaher	$204.85	36.69%	Rajesh KumarHSBC 58%	250 280	Previous Hold Current Buy	Get Alert
Apr 10, 2024	DHRDanaher	$204.85	26.92%	Luke SergottBarclays 67%	240 260	Previous Equal-Weight Current Equal-Weight	Get Alert
Apr 8, 2024	DHRDanaher	$204.85	22.04%	Conor McNamaraRBC Capital 42%	250 270	Previous Outperform Current Outperform	Get Alert
Feb 1, 2024	DHRDanaher	$204.85	41.57%	Paul KnightKeybanc 54%	260 290	Previous Overweight Current Overweight	Get Alert
Jan 31, 2024	DHRDanaher	$204.85	31.8%	Andrew CooperRaymond James 54%	240 270	Previous Outperform Current Outperform	Get Alert
Jan 31, 2024	DHRDanaher	$204.85	37.66%	Conor McNamaraRBC Capital 42%	254 282	Previous Outperform Current Outperform	Get Alert
Jan 31, 2024	DHRDanaher	$204.85	36.69%	Patrick DonnellyCitigroup 64%	255 280	Previous Buy Current Buy	Get Alert
Jan 24, 2024	DHRDanaher	$204.85	17.16%	Luke SergottBarclays 67%	240	Previous Overweight Current Equal-Weight	Get Alert
Dec 20, 2023	DHRDanaher	$204.85	31.8%	Rachel VatnsdalJP Morgan 68%	250 270	Previous Overweight Current Overweight	Get Alert

Recent Analyst Stock Rating News

PRO

Truist Securities Initiates Coverage On Nebius Group with Buy Rating, Announces Price Target of $355

Truist Securities analyst Arvind Ramnani initiates coverage on Nebius Group (NASDAQ:NBIS) with a Buy rating and announces Price Target of $355.

PRO

Oppenheimer Maintains Outperform on Opus Genetics, Raises Price Target to $20

Oppenheimer analyst Andreas Argyrides maintains Opus Genetics (NASDAQ:IRD) with a Outperform and raises the price target from $10 to $20.

PRO

Scotiabank Initiates Coverage On DoorDash with Sector Outperform Rating, Announces Price Target of $275

Scotiabank initiates coverage on DoorDash (NASDAQ:DASH) with a Sector Outperform rating and announces Price Target of $275.

PRO

Scotiabank Initiates Coverage On Uber Technologies with Sector Outperform Rating, Announces Price Target of $100

Scotiabank analyst Nat Schindler initiates coverage on Uber Technologies (NYSE:UBER) with a Sector Outperform rating and announces Price Target of $100.

PRO

Citigroup Maintains Neutral on ServiceTitan, Lowers Price Target to $76

Citigroup analyst Tyler Radke maintains ServiceTitan (NASDAQ:TTAN) with a Neutral and lowers the price target from $83 to $76.

PRO

Citigroup Maintains Buy on Ryman Hospitality Props, Raises Price Target to $135

Citigroup analyst Nick Joseph maintains Ryman Hospitality Props (NYSE:RHP) with a Buy and raises the price target from $125 to $135.

PRO

Citigroup Maintains Neutral on Polaris, Lowers Price Target to $67

Citigroup analyst James Hardiman maintains Polaris (NYSE:PII) with a Neutral and lowers the price target from $73 to $67.

PRO

Citigroup Maintains Neutral on Lululemon Athletica, Lowers Price Target to $117

Citigroup analyst Paul Lejuez maintains Lululemon Athletica (NASDAQ:LULU) with a Neutral and lowers the price target from $130 to $117.

PRO

DA Davidson Maintains Neutral on WaFd, Lowers Price Target to $37

DA Davidson analyst Jeff Rulis maintains WaFd (NASDAQ:WAFD) with a Neutral and lowers the price target from $40 to $37.

PRO

DA Davidson Maintains Buy on United Community Banks, Raises Price Target to $42

DA Davidson analyst Gary Tenner maintains United Community Banks (NYSE:UCB) with a Buy and raises the price target from $40 to $42.

The Best Trading Research Platform

For Retail Investors and Professional Trades Alike.

Get Started for Free

What Are Analyst Stock Ratings?

Analyst ratings measure the expected performance of a stock during a given time period. Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders.

Analysts arrive at stock ratings after they research companies’ public financial statements, communicate with executives and customers and interact with companies in other ways.

Most analysts issue ratings 4 times a year, usually at 3-month intervals.

How to Use Analyst Ratings

As an investor or trader, you want to be able to use analyst ratings effectively. Here are steps you can take to understand how to synthesize all the information analysts report about a particular company and how to apply it to your own trades.

Step 1: Check Ratings History

In the short term, look to see whether analysts suggest an initiation, upgrade or downgrade for a particular stock. Understand how the rating changed compared to the previous rating and whether a price target gets announced or changed.

Sometimes the rating stays the same and only the price target changes, which could cause the stock to move in either direction, depending on the significance of the change between the 2 price targets.

Step 2: Check for Other News

In the short term, check to see how the stock reacts to positive or negative news. This will be an indication of the company’s outlook because analyst ratings usually come out after the company announces news (it’ll typically be earnings news).

Step 3: Look at the Sector for News

Check to see if other stocks in the sector also received similar ratings. This could indicate micro news, which refers to when the whole sector or specific company trades in a specific way due to news outside of one company.

Step 4: Look at the Note

If available, look over the analyst note itself. The beginning of the note has the main information of the rating and price target. Investors should also take a look at the summary of the note, which you can find in the first couple pages and give you a concrete overview of the company. This can help you get an understanding of how analysts arrived at their thesis on the stock.

An example of an analyst note. Source: Needham

Step 5: Make a Decision

After reviewing the analyst ratings (and whether the analyst proposes a change or initiation) and find the reason for that note. Make a decision based on the analyst thesis on the company. This should give you guidance on how to make your thesis. Analyst ratings are a good indication of what professionals believe the company or sector will do, helping you get a better understanding of the companies you’re interested in.

Analyst Rating Accuracy

Analyst ratings are not set in stone and nobody knows indefinitely what a stock will do. Therefore, analyst ratings should be taken as an educated guess made by professionals who carefully study the specific company and sector in question. It's not a surprise that the accuracy of each rating can vary by each individual analyst and specific ratings on companies.

In other words, there’s no hard number or percentage on how accurate analyst ratings are because they are like educated guesses on what they think the stock will do based on their research, within that particular sector. In addition, each firm has so many analysts and so many different companies to review that you can compare ratings to glean what you believe is the truth.

Where Analyst Ratings Come From

Analyst ratings come from stock analysts. Analysts “go deep” on companies within a particular industry or sector. Some analysts employ a top-down approach (they start with an industry or sector and look for excellent companies within that industry or sector) and other stock analysts choose a bottom-up approach, which means they start with the company first and connect the dots within that company’s sector or industry. Analysts evaluate:

Financial statements
Economic fundamentals
Suppliers, customers and competitors
Management quality
Business model
Revenue
Expenses
Assets
Liabilities

While these evaluations are done using facts and figures that any investor can access, they come down to a conclusion the analyst must draw. While this isn’t an unqualified opinion, analysts will disagree because their interpretations of the data could vary.

Types of Stock Ratings

Stock ratings can range from simple “buy” and “sell” ratings to “equal weight” and “outperform” ratings. Here’s a quick overview of how analysts rate stocks.

Buy Rating

A “buy” rating indicates that an analyst is optimistic about a stock’s short-term or mid-term growth and recommends that traders purchase the stock. An analyst may even go so far as to indicate that a stock is a “strong buy.” At the same time, you may choose to swing trade the asset for a profit and come back later to start the process all over again.

Sell Rating

A “sell” rating means that an analyst believes the stock will trend downward in a particular time frame. Analysts might even refer to a security as a “strong sell.” Remember, though, you may want to swing trade and come back to this asset in the future even though you just chose to sell, just as you would under a “buy” rating.

Hold

A “hold” rating suggests that investors should not buy more of or sell the specified stock because they believe the stock should perform in a way that’s consistent with the market or will perform similarly to comparable companies within that particular sector. This is akin to the value investing approach that Warren Buffett uses, looking to gain long-term value from a single stock rather than flipping it because of a bad week. As many have said, it’s not a loss until you sell.

Underperform

An “underperform” rating means an analyst indicates that a stock is expected to perform below the market or sector average. And yes, while the underperform rating may not bode well for an asset in the next few weeks, it may not stay that way. Continue to carefully monitor your portfolio to ensure that an underperforming asset hasn’t turned itself around. As companies are faced with the Herculean task of pleasing shareholders, they will push to fix their underperforming stocks, meaning that a stock you wrote off could rise again.

Outperform

An “outperform” rating means that an analyst expects a stock to outperform the market or sector average. While the stock may look to outperform the market or a sector’s average, that doesn’t mean it will continue to soar forever. You must look at an outperform rating as what that asset will do in recent times, but it may not maintain that trajectory.

Equal-Weight

An equal weight rating means that an analyst believes that an individual stock's performance will tie to the average of all the stocks that an analyst covers in that particular sector. This type of rating helps investors get a true comparison of stocks to each other within a particular sector or industry. At the same time, equal-weight ratings could change at any time.

Price Target

A price target is an analyst’s projection of a stock’s future price. A price target is generally set up in a general trade or area where the asset might land. This means that the analyst could get close without hitting the figure on the head. Even so, the analyst wants to get close and better predict the movement of the marketplace and the asset.

Understanding Stock Ratings

Stock ratings are assessments of the investment potential of a particular stock. They are typically created by financial analysts who evaluate a company's financial performance, competitive positioning, and market outlook to provide guidance on the stock's expected future performance.

Ratings typically range from "buy" to "sell," with variations in between, such as "hold," "accumulate," or "neutral." A "buy" rating suggests that the stock is likely to perform well in the future, and investors should consider purchasing it. Conversely, a "sell" rating indicates that the stock is expected to underperform, and investors should consider selling it.

It's important to note that ratings are not guarantees of performance and should not be relied upon solely when making investment decisions. Ratings are just one factor to consider when evaluating a stock's potential, and investors should also conduct their own research and analysis to make informed decisions.

Another thing to keep in mind is that different analysts may have different opinions on a stock, so it's a good idea to consider multiple ratings before making an investment decision.

In addition to analyst ratings, investors can also consider other factors when evaluating a stock, such as its financial statements, management team, industry trends, and overall market conditions. By combining all of these factors, investors can make informed decisions about which stocks to buy or sell.

In summary, stock ratings are an important tool for investors to consider when evaluating a stock's potential, but they should not be the only factor used in investment decision-making. It's important to conduct your own research, consider multiple ratings, and take into account other factors before making an investment decision.

Should You Use Analyst Ratings to Inform Your Own Trades?

You can definitely use analyst ratings to inform your own trades and inform your own thesis but it’s a good idea to do your own research. However, analyst ratings are just one step in what should be a much larger investment strategy. Don’t fall in love with just one analyst. Compare notes. Look into how these ratings match with activity on the market and current events. Plus, remember that an analyst rating could easily be incorrect. No one is perfect, but these ratings are a good place to start.

Visit Benzinga News for more guidance on how to research companies and make decisions about research, trading and investing.

Compare Online Stock Brokers

Claim Exclusive Offers

Interactive Brokers Review
Good Fit For:
Active and Global Traders
VIEW PROS & CONS:
Securely through Interactive Brokers’ website
Plus500 Review
Good Fit For:
Leveraged Trading
VIEW PROS & CONS:
securely through Plus500 Yield's website
public.com Review
Good Fit For:
Trading Ideas
VIEW PROS & CONS:
securely through public.com's website
Robinhood Review
Good Fit For:
Commission-Free Mobile Trading
VIEW PROS & CONS:
securely through Robinhood's website
TradeZero Review
Good Fit For:
Active Short Sellers
VIEW PROS & CONS:
securely through TradeZero [SPONSORED]'s website